Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures

Nature biotechnology

Nikolai Eroshenko, Taylor Gill, Marianna K Keaveney, George M Church, Jose M Trevejo, Hannu Rajaniemi

• DOI: 10.1038/s41587-020-0577-1
• PMID: 32504046